malaria

malaria, infectious parasitic disease that can be either acute or chronic and is frequently recurrent. Malaria is common in Africa, Central and South America, the Mediterranean countries, Asia, and many of the Pacific islands. In the United States it was found in the South and less frequently in the northern and western parts of the country.

The primary causative organism, Plasmodium falciparum, requires both the Anopheles mosquito and humans to complete its life cycle: sexual reproduction of the protozoan occurs in the mosquito; an immature form is then transmitted to the human via the bite of the mosquito. In a person the parasite goes to the liver, replicates, and moves into the bloodstream, where it attacks red blood cells for their hemoglobin. Some of the plasmodia become sexually mature and are transmitted back to another biting mosquito. Three other Plasmodium species also infect humans.

Symptoms

At the onset of malaria, bouts of chills (ague) and fever lasting several hours and occurring every three or four days are the usual symptoms. If the disease is not treated, the spleen and the liver become enlarged, anemia develops, and jaundice appears. Death may occur from general debility, anemia, or clogging of the vessels of cerebral tissues by affected red blood cells. Cerebral malaria is most commonly seen in infants, pregnant women, and nonimmune travelers to endemic areas.

Immune Response

P. falciparum creates protein knobs on the surfaces of the red blood cells it attacks. These knobs attach the cell to the lining of the blood vessel, preventing its removal to the spleen for destruction. The parasite slows detection by the immune system by changing the makeup of the knobs periodically, substituting or rearranging its 150 "var" (variability) genes, a strategy unique to malaria. A pattern of remission and relapse results as the immune system learns each new "code" only to have it again changed. Patients with malaria gradually do develop immunity that modifies the course of the disease, but this immunity has a degree of strain specificity.

Treatment and Control

The bark of the cinchona and its product, quinine, have been used in the treatment of malaria for centuries. After World War II, they were largely replaced by the synthetic analog chloroquine. The use of chloroquine, in addition to the use of DDT for mosquito control, was expected to eradicate the disease, but a World Health Organization campaign (1955–69) to eradicate the disease globally (by controlling mosquitoes long enough to allow the human population to become disease free) proved unsuccessful. Despite that, spraying successfully eradicated the disease in some areas (Sardinia, Japan, and Taiwan).

In the 1960s several strains of the malarial parasite developed resistance to chloroquine. This, plus the growing immunity of mosquitoes to insecticides, has caused malaria to become one the of world's leading re-emerging infectious diseases, infecting an estimated 300 million people a year and killing more than a million. Mefloquine may be used in areas where the disease has become highly resistant to chloroquine, but some strains are now resistant to it and other drugs. Artemisinin (derived from sweet wormwood) in combination with other drugs is now in many cases the preferred treat for resistant strains. Amodiaquine in combination with sulfadoxine and pyrimethamine has also been shown to be effective, and malarone (atovaquone and proguanil) also is used for resistant strains. Vaccines against malaria are still experimental. Spraying is still used to control malaria-transmitting mosquitoes, but fish that feed on mosquito larva also have been employed.

---

malaria

A serious relapsing infection caused by protozoa of the genus Plasmodium (see plasmodium), transmitted by the bite of the Anopheles mosquito. Known since before the 5th century BC, it occurs in tropical and subtropical regions near swamps. The roles of the mosquito and the parasite were proved in the early 20th century. Annual cases worldwide are estimated at 250 million and deaths at 2 million. Malaria from different Plasmodium species differs in severity, mortality, and geographic distribution. The parasites have an extremely complex life cycle; in one stage they develop synchronously inside red blood cells. Their mass fissions at 48- or 72-hour intervals cause attacks lasting 4–10 hours. Shaking and chills are followed by fever of up to 105 °F (40.6 °C), with severe headache and then profuse sweating as temperature returns to normal. Patients often have anemia, spleen enlargement, and general weakness. Complications can be fatal. Malaria is diagnosed by detecting the parasites in blood. Quinine was long used to alleviate the fevers. Synthetic drugs, such as chloroquine, destroy the parasites in blood cells, but many strains are now resistant. Carriers of a gene for a hemoglobinopathy have natural resistance. Malaria prevention requires preventing mosquito bites: eliminating mosquito breeding places and using insecticides or natural predators, window screens, netting, and insect repellent. See also protozoal disease.

---

malaria

an infectious disease characterized by recurring attacks of chills and fever, caused by the bite of an anopheles mosquito infected with any of four protozoans of the genus Plasmodium (P. vivax, P. falciparum, P. malariae, or P. ovale)

---

malaria [mə′ler·ē·ə]

(medicine)

A group of human febrile diseases with a chronic relapsing course caused by hemosporidian blood parasites of the genusPlasmodium,transmitted by the bite of theAnophelesmosquito.